Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis.

BioMed research international - 1 Jan 2020

Feng Tongbao, Zhang Ping, Sun Yingxin, Han Xiu, Tong Jichun, Hua Zichun

Abstract excerpt

PURPOSE: Breast invasive carcinoma (BRCA) is the most common malignant tumor. MiR-124 plays a tumor-suppressive role in human cancer. However, the clinical significance of miR-124 in BRCA remains unclear. The aim of this study was to evaluate the association of hsa-mir-124 expression and the clinicopathological characteristics in BRCA using database analysis. METHODS: The clinical data and expression profiles of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to Gene Expression Profiling

Share to Gene Expression Regulation, Neoplastic

Share to Lymphatic Metastasis

Share to MicroRNAs

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 32190652
DOI: 10.1155/2020/1839205
PMCID: PMC7073497

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis.PMID 32190652Read ↗

Exosomal miR-1246 is Involved in Tumorigenesis by Targeting THRB in Breast CancerSemantic proximity Read ↗

Prognosis assessment of CD44+/CD24- in Breast Cancer Patients: a systematic review and meta-analysisSemantic proximity Read ↗

MiR-324-5P Functions as a Novel Serum Biomarker and Modulates Breast Cancer Malignant ActivitySemantic proximity Read ↗

The BRCA1/2-directed miRNA signature predicts a good prognosis in ovarian cancer patients with wild-type BRCA1/2.Semantic proximity Read ↗

Role of miR-139 as a surrogate marker for tumor aggression in breast cancer.Semantic proximity Read ↗

CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.Semantic proximity Read ↗

Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.Semantic proximity Read ↗

Hsa-miR-599 suppresses the migration and invasion by targeting BRD4 in breast cancerSemantic proximity Read ↗

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast CancerSemantic proximity Read ↗

Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancerSemantic proximity Read ↗

Decreased miR-124-3p Expression Prompted Breast Cancer Cell Progression Mainly by Targeting Beclin-1Semantic proximity Read ↗

Expression and prognostic value of hsa-miR-206 in non-triple-negative breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.